The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts
- 1 April 2024
- journal article
- review article
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (8) , 2858-2872
Abstract
Ferumoxytol is an ultrasmall superparamagnetic iron oxide which has been used as an off-label intravenous contrast agent for MRI. Unlike gadolinium-based contrast agents, ferumoxytol remains in the intravascular space with a long half-life of 14–21 h. During the first several hours, it acts as a blood-pool agent and has minimal parenchymal enhancement. Studies have shown adequate intravascular signal for up to 72 h after initial contrast bolus. Ferumoxytol has been shown to be safe, even in patients with renal failure. Ferumoxytol has shown promise in a variety of clinical settings. The exquisite resolution enabled by the long intravascular times and lack of background parenchymal enhancement is of particular interest in the vascular imaging of solid organ allografts. Ferumoxytol magnetic resonance angiography (MRA) may identify clinically actionable findings months before ultrasound, CT angiography, or Gadolinium-enhanced MRA. Ferumoxytol MRA is of particular benefit as a troubleshooting tool in the setting of equivocal ultrasound and CT imaging. In the following review, we highlight the use of ferumoxytol for high-resolution MR vascular imaging for abdominal solid organ allografts, with representative cases. Graphical abstractKeywords
This publication has 51 references indexed in Scilit:
- Ultrasmall superparamagnetic iron oxide nanoparticles: A next generation contrast agent for magnetic resonance imagingWIREs Nanomedicine and Nanobiotechnology, 2021
- How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytolPediatric Radiology, 2021
- Safety of Off‐Label Use of Ferumoxtyol as a Contrast Agent for MRI: A Systematic Review and Meta‐Analysis of Adverse EventsJournal of Magnetic Resonance Imaging, 2020
- Pictorial review on abdominal applications of ferumoxytol in MR imagingAbdominal Radiology, 2019
- The role of MR imaging in the assessment of renal allograft vasculatureAbdominal Radiology, 2018
- Vascular complications in kidney transplant recipientsAbdominal Radiology, 2018
- Comparison of ferumoxytol‐enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosisJournal of Magnetic Resonance Imaging, 2016
- Emerging applications for ferumoxytol as a contrast agent in MRIJournal of Magnetic Resonance Imaging, 2014
- Magnetic Resonance Angiography2012
- First‐pass contrast‐enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)‐based blood pool agentJournal of Magnetic Resonance Imaging, 2004